Home/Filings/4/0001209191-05-046301
4//SEC Filing

MPM BIOVENTURES III PARALLEL FUND 4

Accession 0001209191-05-046301

CIK 0001262175other

Filed

Sep 6, 8:00 PM ET

Accepted

Sep 7, 6:23 PM ET

Size

18.5 KB

Accession

0001209191-05-046301

Insider Transaction Report

Form 4
Period: 2005-09-02
Transactions
  • Sale

    Common Stock

    2005-09-02$12.49/sh96,630$1,206,7356,967,864 total(indirect: See footnote)
  • Sale

    Common Stock

    2005-09-06$12.01/sh98,196$1,179,1576,869,668 total(indirect: See footnote)
Transactions
  • Sale

    Common Stock

    2005-09-06$12.01/sh98,196$1,179,1576,869,668 total(indirect: See footnote)
  • Sale

    Common Stock

    2005-09-02$12.49/sh96,630$1,206,7356,967,864 total(indirect: See footnote)
Transactions
  • Sale

    Common Stock

    2005-09-06$12.01/sh98,196$1,179,1576,869,668 total(indirect: See footnote)
  • Sale

    Common Stock

    2005-09-02$12.49/sh96,630$1,206,7356,967,864 total(indirect: See footnote)
Transactions
  • Sale

    Common Stock

    2005-09-06$12.01/sh98,196$1,179,1576,869,668 total(indirect: See footnote)
  • Sale

    Common Stock

    2005-09-02$12.49/sh96,630$1,206,7356,967,864 total(indirect: See footnote)
Transactions
  • Sale

    Common Stock

    2005-09-02$12.49/sh96,630$1,206,7356,967,864 total(indirect: See footnote)
  • Sale

    Common Stock

    2005-09-06$12.01/sh98,196$1,179,1576,869,668 total(indirect: See footnote)
Transactions
  • Sale

    Common Stock

    2005-09-02$12.49/sh96,630$1,206,7356,967,864 total(indirect: See footnote)
  • Sale

    Common Stock

    2005-09-06$12.01/sh98,196$1,179,1576,869,668 total(indirect: See footnote)
Transactions
  • Sale

    Common Stock

    2005-09-02$12.49/sh96,630$1,206,7356,967,864 total(indirect: See footnote)
  • Sale

    Common Stock

    2005-09-06$12.01/sh98,196$1,179,1576,869,668 total(indirect: See footnote)
Footnotes (4)
  • [F1]The shares were sold as follows: 80,411 by MPM BioVentures III-QP, LP ("BVQP"), 5,406 by MPM BioVentures III, LP ("BVLP"), 2,429 by MPM BioVentures III Parallel Fund, LP ("BVPF"), 6,795 by MPM BioVentures III GmbH & Co. Beteiligungs KG ("BVKG") and 1,589 by MPM Asset Management Investors 2002 BVIII LLC ("BVAM"). MPM BioVentures III GP, LP ("BVGP") and MPM BioVentures III LLC ("BVLLC") are the indirect and direct general partners of BVQP, BVLP, BVPF and BVKG. Luke Evnin ("LE"), Ansbert Gadicke ("AG"), Nicholas Galakatos ("NG"), Dennis Henner ("DH"), Nicholas Simon III ("NS"), Michael Steinmetz ("MS") and Kurt Wheeler ("KW") are the members of BVLLC. LE, AG, NG, DH, NS, MS and KW are members of BVAM.
  • [F2]The shares are held as follows: 5,796,640 by BVQP, 389,740 by BVLP, 175,121 by BVPF, 489,839 by BVKG, 114,524 by BVAM and 2,000 by KW. Each member of the group disclaims beneficial ownership of the securities except to the extent of its pecuniary interest therein.
  • [F3]The shares were sold as follows: 81,714 by BVQP, 5,494 by BVLP, 2,469 by BVPF, 6,905 by BVKG and 1,614 by BVAM.
  • [F4]The shares are held as follows: 5,714,926 by BVQP, 384,246 by BVLP, 172,652 by BVPF, 482,934 by BVKG, 112,910 by BVAM and 2,000 by KW. Each member of the group disclaims beneficial ownership of the securities except to the extent of its pecuniary interest therein.

Issuer

TERCICA INC

CIK 0001262175

Entity typeother
IncorporatedDE

Related Parties

1
  • filerCIK 0001249063

Filing Metadata

Form type
4
Filed
Sep 6, 8:00 PM ET
Accepted
Sep 7, 6:23 PM ET
Size
18.5 KB